Skip to main content
Top
Published in: Journal of NeuroVirology 1/2011

Open Access 01-02-2011

Neurocognitive functioning in acute or early HIV infection

Authors: David J. Moore, Scott L. Letendre, Sheldon Morris, Anya Umlauf, Reena Deutsch, Davey M. Smith, Susan Little, Alexandra Rooney, Donald R. Franklin, Ben Gouaux, Shannon LeBlanc, Debra Rosario, Christine Fennema-Notestine, Robert K. Heaton, Ronald J. Ellis, J. Hampton Atkinson, Igor Grant, for the CHARTER Group

Published in: Journal of NeuroVirology | Issue 1/2011

Login to get access

Abstract

We examined neurocognitive functioning among persons with acute or early HIV infection (AEH) and hypothesized that the neurocognitive performance of AEH individuals would be intermediate between HIV seronegatives (HIV−) and those with chronic HIV infection. Comprehensive neurocognitive testing was accomplished with 39 AEH, 63 chronically HIV infected, and 38 HIV− participants. All AEH participants were HIV infected for less than 1 year. Average domain deficit scores were calculated in seven neurocognitive domains. HIV−, AEH, and chronically HIV infected groups were ranked from best (rank of 1) to worst (rank of 3) in each domain. All participants received detailed substance use, neuromedical, and psychiatric evaluations and HIV infected persons provided information on antiretroviral treatment and completed laboratory evaluations including plasma and CSF viral loads. A nonparametric test of ordered alternatives (Page test), and the appropriate nonparametric follow-up test, was used to evaluate level of neuropsychological (NP) functioning across and between groups. The median duration of infection for the AEH group was 16 weeks [interquartile range, IQR: 10.3–40.7] as compared to 4.9 years [2.8–11.1] in the chronic HIV group. A Page test using ranks of average scores in the seven neurocognitive domains showed a significant monotonic trend with the best neurocognitive functioning in the HIV− group (mean rank = 1.43), intermediate neurocognitive functioning in the AEH group (mean rank = 1.71), and the worst in the chronically HIV infected (mean rank = 2.86; L statistic = 94, p < 0.01); however, post-hoc testing comparing neurocognitive impairment of each group against each of the other groups showed that the chronically infected group was significantly different from both the HIV− and AEH groups on neurocognitive performance; the AEH group was statistically indistinguishable from the HIV− group. Regression models among HIV infected participants were unable to identify significant predictors of neurocognitive performance. Neurocognitive functioning was worst among persons with chronic HIV infection. Although a significant monotonic trend existed and patterns of the data suggest the AEH individuals may fall intermediate to HIV− and chronic participants, we were not able to statistically confirm this hypothesis.
Literature
go back to reference Akaike H (1974) New look at the statistical-model identification. IEEE Transactions on Automatic Control Ac 19:716–723CrossRef Akaike H (1974) New look at the statistical-model identification. IEEE Transactions on Automatic Control Ac 19:716–723CrossRef
go back to reference Ances BM, Sisti D, Vaida F, Liang CL, Leontiev O et al (2009) Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain. Neurology 73:702–708CrossRefPubMed Ances BM, Sisti D, Vaida F, Liang CL, Leontiev O et al (2009) Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain. Neurology 73:702–708CrossRefPubMed
go back to reference Beck AT, Steer RA, Brown G (1996) BDI-II Manual. The Psychological Corp, San Antonio Beck AT, Steer RA, Brown G (1996) BDI-II Manual. The Psychological Corp, San Antonio
go back to reference Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD et al (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26:307–319CrossRefPubMed Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD et al (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26:307–319CrossRefPubMed
go back to reference Cherner M, Suarez P, Lazzaretto D, Fortuny LA, Mindt MR et al (2007) Demographically corrected norms for the Brief Visuospatial Memory Test-revised and Hopkins Verbal Learning Test-revised in monolingual Spanish speakers from the U.S.–Mexico border region. Arch Clin Neuropsychol 22:343–353CrossRefPubMed Cherner M, Suarez P, Lazzaretto D, Fortuny LA, Mindt MR et al (2007) Demographically corrected norms for the Brief Visuospatial Memory Test-revised and Hopkins Verbal Learning Test-revised in monolingual Spanish speakers from the U.S.–Mexico border region. Arch Clin Neuropsychol 22:343–353CrossRefPubMed
go back to reference Daar ES, Moudgil T, Meyer RD, Ho DD (1991) Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 324:961–964CrossRefPubMed Daar ES, Moudgil T, Meyer RD, Ho DD (1991) Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 324:961–964CrossRefPubMed
go back to reference Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT et al (2003) Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17:1871–1879CrossRefPubMed Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT et al (2003) Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17:1871–1879CrossRefPubMed
go back to reference Grant I, Atkinson JH, Hesselink JR, Kennedy CJ, Richman DD et al (1987) Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. Ann Intern Med 107:828–836PubMed Grant I, Atkinson JH, Hesselink JR, Kennedy CJ, Richman DD et al (1987) Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. Ann Intern Med 107:828–836PubMed
go back to reference Heaton R, Miller S, Taylor M, Grant I (2004a) Revised comprehensive norms for an expanded Halstead-Reitan battery: demographically adjusted neuropsychological norms for African American and Caucasian adults. Psychological Assessment Resources, Lutz, FL Heaton R, Miller S, Taylor M, Grant I (2004a) Revised comprehensive norms for an expanded Halstead-Reitan battery: demographically adjusted neuropsychological norms for African American and Caucasian adults. Psychological Assessment Resources, Lutz, FL
go back to reference Heaton, RK, Clifford, DB, Franklin Jr., DR, Woods, SP, Ake, C, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy. Neurology (In press) Heaton, RK, Clifford, DB, Franklin Jr., DR, Woods, SP, Ake, C, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy. Neurology (In press)
go back to reference Heaton RK, Grant I, Butters N, White DA, Kirson D et al (1995) The HNRC 500–neuropsychology of HIV infection at different disease stages HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1:231–251CrossRefPubMed Heaton RK, Grant I, Butters N, White DA, Kirson D et al (1995) The HNRC 500–neuropsychology of HIV infection at different disease stages HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1:231–251CrossRefPubMed
go back to reference Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ et al (2004b) The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10:317–331CrossRefPubMed Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ et al (2004b) The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10:317–331CrossRefPubMed
go back to reference Heaton RK, Taylor MJ, Manly J (2003) Demographic effects and use of demographically corrected norms with the WAIS-III and WMS-III. In: Tulsky DS, Saklofske DH, Chelune GJ, Heaton RK, Ivnik RJ et al (eds) Clinical Interpretation of the WAIS-III and WMS-III. Academic, San Diego, pp 183–209 Heaton RK, Taylor MJ, Manly J (2003) Demographic effects and use of demographically corrected norms with the WAIS-III and WMS-III. In: Tulsky DS, Saklofske DH, Chelune GJ, Heaton RK, Ivnik RJ et al (eds) Clinical Interpretation of the WAIS-III and WMS-III. Academic, San Diego, pp 183–209
go back to reference Heaton RK, Velin RA, McCutchan JA, Gulevich SJ, Atkinson JH et al (1994) Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med 56:8–17PubMed Heaton RK, Velin RA, McCutchan JA, Gulevich SJ, Atkinson JH et al (1994) Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med 56:8–17PubMed
go back to reference Kothe D, Byers RH, Caudill SP, Satten GA, Janssen RS et al (2003) Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J Acquir Immune Defic Syndr 33:625–634CrossRefPubMed Kothe D, Byers RH, Caudill SP, Satten GA, Janssen RS et al (2003) Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J Acquir Immune Defic Syndr 33:625–634CrossRefPubMed
go back to reference Lentz MR, Kim WK, Lee V, Bazner S, Halpern EF et al (2009) Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection. Neurology 72:1465–1472CrossRefPubMed Lentz MR, Kim WK, Lee V, Bazner S, Halpern EF et al (2009) Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection. Neurology 72:1465–1472CrossRefPubMed
go back to reference Little SJ, McLean AR, Spina CA, Richman DD, Havlir DV (1999) Viral dynamics of acute HIV-1 infection. J Exp Med 190:841–850CrossRefPubMed Little SJ, McLean AR, Spina CA, Richman DD, Havlir DV (1999) Viral dynamics of acute HIV-1 infection. J Exp Med 190:841–850CrossRefPubMed
go back to reference Mandal N, Singh OP, Bhattacharya S, Chatterji S, Biswas A, Sen S (2008) Neurocognitive impairment in early HIV-positive individuals. J Indian Med Assoc 106(442):47–49, p. 53 Mandal N, Singh OP, Bhattacharya S, Chatterji S, Biswas A, Sen S (2008) Neurocognitive impairment in early HIV-positive individuals. J Indian Med Assoc 106(442):47–49, p. 53
go back to reference Marcotte TD, Lazzaretto D, Scott JC, Roberts E, Woods SP, Letendre S (2006) Visual attention deficits are associated with driving accidents in cognitively-impaired HIV-infected individuals. J Clin Exp Neuropsychol 28:13–28CrossRefPubMed Marcotte TD, Lazzaretto D, Scott JC, Roberts E, Woods SP, Letendre S (2006) Visual attention deficits are associated with driving accidents in cognitively-impaired HIV-infected individuals. J Clin Exp Neuropsychol 28:13–28CrossRefPubMed
go back to reference Page EB (1963) Ordered hypotheses for multiple treatments: A significance test for linear ranks. J Am Stat Assoc 58:216–230CrossRef Page EB (1963) Ordered hypotheses for multiple treatments: A significance test for linear ranks. J Am Stat Assoc 58:216–230CrossRef
go back to reference Peterson, J, Lee, E, Hecht, F, Price, R, Robertson, K, Spudich, S. 2010. Neurocognitive performance during primary HIV-1 infection. 17th Conference on Retroviruses and Opportunistic Infections, p. Poster 424. San Francisco, California Peterson, J, Lee, E, Hecht, F, Price, R, Robertson, K, Spudich, S. 2010. Neurocognitive performance during primary HIV-1 infection. 17th Conference on Retroviruses and Opportunistic Infections, p. Poster 424. San Francisco, California
go back to reference Reger M, Welsh R, Razani J, Martin DJ, Boone KB (2002) A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc 8:410–424CrossRefPubMed Reger M, Welsh R, Razani J, Martin DJ, Boone KB (2002) A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc 8:410–424CrossRefPubMed
go back to reference Schacker TW, Hughes JP, Shea T, Coombs RW, Corey L (1998) Biological and Virologic Characteristics of Primary HIV Infection. Ann Intern Med 128:613–620PubMed Schacker TW, Hughes JP, Shea T, Coombs RW, Corey L (1998) Biological and Virologic Characteristics of Primary HIV Infection. Ann Intern Med 128:613–620PubMed
go back to reference Sevigny JJ, Albert SM, McDermott MP, Schifitto G, McArthur JC et al (2007) An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol 64:97–102CrossRefPubMed Sevigny JJ, Albert SM, McDermott MP, Schifitto G, McArthur JC et al (2007) An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol 64:97–102CrossRefPubMed
go back to reference Siegel S, Castellan NJ Jr (1988) Nonparametric statistics for the behavioral sciences. McGraw-Hill, New York Siegel S, Castellan NJ Jr (1988) Nonparametric statistics for the behavioral sciences. McGraw-Hill, New York
go back to reference Tambussi G, Gori A, Capiluppi B, Balotta C, Papagno L et al (2000) Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid. Clin Infect Dis 30:962–965CrossRefPubMed Tambussi G, Gori A, Capiluppi B, Balotta C, Papagno L et al (2000) Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid. Clin Infect Dis 30:962–965CrossRefPubMed
go back to reference Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF et al (2007) Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr 45:174–182CrossRefPubMed Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF et al (2007) Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr 45:174–182CrossRefPubMed
go back to reference Volberding P, Demeter L, Bosch RJ, Aga E, Pettinelli C et al (2009) Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment. AIDS 23:1987–1995CrossRefPubMed Volberding P, Demeter L, Bosch RJ, Aga E, Pettinelli C et al (2009) Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment. AIDS 23:1987–1995CrossRefPubMed
go back to reference Wittchen HU, Robins LN, Cottler LB, Sartorius N, Burke JD, Regier D (1991) Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The Multicentre WHO/ADAMHA Field Trials. Br J Psychiatry 159(645–53):58 Wittchen HU, Robins LN, Cottler LB, Sartorius N, Burke JD, Regier D (1991) Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The Multicentre WHO/ADAMHA Field Trials. Br J Psychiatry 159(645–53):58
go back to reference Woods SP, Dawson MS, Weber E, Gibson S, Grant I, Atkinson JH (2009a) Timing is everything: antiretroviral nonadherence is associated with impairment in time-based prospective memory. J Int Neuropsychol Soc 15:42–52CrossRefPubMed Woods SP, Dawson MS, Weber E, Gibson S, Grant I, Atkinson JH (2009a) Timing is everything: antiretroviral nonadherence is associated with impairment in time-based prospective memory. J Int Neuropsychol Soc 15:42–52CrossRefPubMed
go back to reference Woods SP, Moore DJ, Weber E, Grant I (2009b) Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 19:152–168CrossRefPubMed Woods SP, Moore DJ, Weber E, Grant I (2009b) Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 19:152–168CrossRefPubMed
go back to reference Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E et al (2004) Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 26:759–778CrossRefPubMed Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E et al (2004) Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 26:759–778CrossRefPubMed
Metadata
Title
Neurocognitive functioning in acute or early HIV infection
Authors
David J. Moore
Scott L. Letendre
Sheldon Morris
Anya Umlauf
Reena Deutsch
Davey M. Smith
Susan Little
Alexandra Rooney
Donald R. Franklin
Ben Gouaux
Shannon LeBlanc
Debra Rosario
Christine Fennema-Notestine
Robert K. Heaton
Ronald J. Ellis
J. Hampton Atkinson
Igor Grant
for the CHARTER Group
Publication date
01-02-2011
Publisher
Springer US
Published in
Journal of NeuroVirology / Issue 1/2011
Print ISSN: 1355-0284
Electronic ISSN: 1538-2443
DOI
https://doi.org/10.1007/s13365-010-0009-y

Other articles of this Issue 1/2011

Journal of NeuroVirology 1/2011 Go to the issue